A 78-year-old woman is evaluated in a skilled nursing facility for abnormal urine characteristics. She was transferred to the facility two weeks ago for rehabilitation following an ischemic stroke. She has a chronic indwelling urethral catheter due to persistent neurogenic bladder. Today, the nursing staff noticed her urine is cloudy and has a strongly offensive odor. The patient is alert, conversant, and oriented to person and place, which represents her baseline cognitive status since the stroke. She denies suprapubic pain, flank pain, nausea, or chills. Her temperature is 37.0°C (98.6°F), blood pressure is 128/78 mm Hg, pulse is 76/min, and respirations are 14/min. Physical examination reveals a soft, non-tender abdomen and no costovertebral angle tenderness. Urinalysis shows a pH of 7.5, positive leukocyte esterase, positive nitrites, and >100 WBCs/hpf. A urine culture grows >10^5 CFU/mL of Proteus mirabilis that is sensitive to amoxicillin, ciprofloxacin, ceftriaxone, and trimethoprim-sulfamethoxazole. Which of the following is the most appropriate next step in management?
- AOral amoxicillin
- Observation without antibiotic therapyCevap
- COral ciprofloxacin
- DIntravenous ceftriaxone
- EDaily prophylactic trimethoprim-sulfamethoxazole